Evaluate the Safety and Efficacy of FG-3019 (Pamrevlumab) in Participants With Idiopathic Pulmonary Fibrosis (IPF)

MHAT 'Tokuda Hospital Sofia', AD, Department of Pulmonology, Sofia

Concord Repatriation, Concord

Tauranga Hospital, Tauranga

Waikato Hospital, Hamilton

Life Mount Edgecombe Hospital, Durban

Daw Park Repatriation, Adelaide

Tygerberg Hospital Respiratory Research Unit, Cape Town

Christchurch Hospital NZ, Christchurch

Dunedin Public Hospital, Dunedin

Columbia University Medical Center, New York

University of Pittsburgh Medical Center, Pittsburgh

University of Maryland, Baltimore

PulmonIx LLC, Greensboro

Emory University, Atlanta

Pensacola Research Consultants, Inc., d.b.a. Avanza Medical Research Center, Pensacola

Pulmonary Disease Specialist, PA, Kissimmee

The Kirklin Clinic, Birmingham

University of Louisville, Louisville

University of Cinncinati, Cincinnati

Henry Ford Medical Center, Detroit

Northwestern University, Chicago

St. Luke's Hospital, Chesterfield

University of Kansas Medical Center, Kansas City

Via Christi Clinic, P.A., Wichita

University of Texas Southwestern Medical Center, Dallas

National Jewish Health, Denver

University of Utah - Lung Health Research, Salt Lake City

David Geffen School of Medicine at UCLA, Los Angeles

UC Davis Medical Center, Sacramento

Legacy Research Institute, Portland

Midland Healthcare & Research Center, Lucknow

Bhatia Hospital, Mumbai

St Johns Medical College Hospital, Bangalore

Sri Bala Medical Centre and Hospital, Coimbatore

Fortis Hospitals, Kolkata

Yale University, New Haven

Steward St. Elizabeth's Medical Center, Boston

Dartmouth-Hitchcock Medical Center, Lebanon

Vanderbilt University, Nashville

Vermont Lung Center, Colchester

Université de Sherbrooke / Hôpital Charles LeMoyne, Greenfield Park

Into Research, Pretoria